Main Outcomes From World AIDS Forum
July 27, 2010
Strong scientific evidence presented at the 18th International AIDS Conference (IAC) in Vienna showed clear progress is possible in fighting HIV/AIDS, though economic woes have made the resource gap wider.
For the health of those living with HIV, treatment should be initiated at a CD4 count of 350 cells/mm3, regardless of the presence or absence of clinical symptoms, the World Health Organization announced at the conference. Earlier access to antiretroviral therapy benefits HIV patients in reduced morbidity and mortality, several recent studies show. Expanded ARV access also reduces HIV incidence in society at large, according to research by International AIDS Society President Dr. Julio Montaner and British Columbia Center for Excellence in HIV/AIDS colleagues.
For years, experts have avoided using the term "eradicate" with respect to HIV, largely because the virus rebounds once treatment stops. Nobel laureate and HIV co-discoverer Francoise Barre-Sinoussi returned to the question of whether viral "reservoirs" can indeed someday be flushed out to eradicate HIV from the body.
The aging of the HIV-positive population was also discussed. Both the virus and ARVs are linked with myriad health effects. Many older patients are now facing cancer, diabetes, heart, liver, and kidney diseases without adequate savings or social support, experts said.
The IAC, which ended July 23, will next be held in Washington, D.C., in 2012.
Agence France Presse
Global Fund Director Calls on Emerging Countries to Invest More in Programs to Reduce HIV/AIDS, TB and Malaria at AIDS 2010
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.